This inventor holds 1 USPTO granted patent. Top assignee: Scripps Research Institute. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Alicia Gonzalez-Martin: Innovator in B Cell Receptor Modification
Introduction
Alicia Gonzalez-Martin is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of immunology, particularly in the modification of B cell receptors. Her innovative work aims to enhance the immune response against various pathogens.
Latest Patents
Alicia holds a patent for "B cell receptor modification in B cells." This patent describes methods and systems for generating engineered B cells with modified immunoglobulin genes. The modified immunoglobulin genes encode modified immunoglobulins that can exhibit high affinity for antigens, including those that are variable, such as the types of antigens found on various pathogens that can evade mammalian immune responses. She has 1 patent to her name.
Career Highlights
Alicia is affiliated with The Scripps Research Institute, where she continues to advance her research in immunology. Her work has the potential to significantly impact therapeutic strategies for infectious diseases and other immune-related conditions.
Collaborations
Alicia collaborates with notable colleagues, including James Even Voss and Raiees Andrabi. These partnerships enhance her research and contribute to the development of innovative solutions in the field.
Conclusion
Alicia Gonzalez-Martin is a trailblazer in the field of B cell receptor modification, with her innovative patent paving the way for advancements in immunotherapy. Her contributions are vital to the ongoing fight against infectious diseases and the enhancement of immune responses.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile